And so far, those results have been very promising
35 Overall, numerous meta-analyses to date have failed to find a statistically significant increase in pancreatitis incidence associated with GLP-1 receptor agonist therapy
The proportion of respondents reporting less consumption of processed foods was about 70 percent more than of those who reported consuming more
doi: 10.1016/j.tem.2024.05.002 Summary Keywords food preferences, gastrointestinal hormones, glucagon-like peptide 1, gut-brain axis, obesity, taste, taste receptors Citation Doval-Caballero JLE, Ferreira-Hermosillo A, Eugenio-Ponce GD, Garca-Senz MR, Ibarra-Salce R, Tenorio-Rojo AP, Luna-Avila ES, Gete-Palacios PC, Prez-Hernndez F, Rojas-Miln E, Lpez-Cruz LA and Mndez-Hernndez CA (2026) Potential role of glucagon like peptide 1 in taste receptors
A1C reduction of 1.7-2.0% across doses at 40 weeks
How often do I need to take GLP-1 injections